Abstract: The present invention relates to extracts of Isochrysis sp., preferably Tahitian Isochrysis, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Isochrysis sp., preferably Tahitian Isochrysis.

Abstract: A cosmetic composition, including compounds of formula (I) in which R and R? independently of one another denote hydrogen, hydroxyl, a linear or branched OC1-C4-alkyl group, or optionally R and R? form together a methylenedioxy group resulting in a 3,4-methylendioxyphenyl residue and R? denotes a linear or branched C1-C9 alkyl group or A, in which A denotes with X, Y and Z being independently of one another hydrogen, hydroxyl, an linear or branched C1-C4-alkyl group, or a linear or branched OC1-C4-alkyl group.

Abstract: Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of purple coneflower pressed juice, sclareolide, ginger root C02 extract, E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Abstract: A cosmetic composition, including compounds of formula (I) in which R and R? independently of one another denote hydrogen, hydroxyl, a linear or branched OC1-C4-alkyl group, or optionally R and R? form together a methylenedioxy group resulting in a 3,4-methylendioxyphenyl residue and R? denotes a linear or branched C1-C9 alkyl group or A, in which A denotes with X, Y and Z being independently of one another hydrogen, hydroxyl, an linear or branched C1-C4-alkyl group, or a linear or branched OC1-C4-alkyl group.

Abstract: Suggested is a cosmetic composition comprising an anti-pollution agent selected from the group consisting of E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one, sclareolide, purple coneflower pressed juice, ginger root CO2 extract or mixtures thereof, in a working amount sufficient for (a) reducing or preventing air pollution induced gene expression, and/or (b) reducing or preventing a gene expression induced or inducible by polycyclic aromatic hydrocarbons, and/or (c) reducing or preventing air pollution-induced or air pollution-inducible skin damage.

Abstract: The invention concerns a blackberry leaf extract and its uses, in particular to slow down skin aging, to treat the oral and pharyngeal cavity, and there in particular to prevent and slow down periodontitis and the excessive degradation of the periodontal connective tissue as well as damage to the teeth caused by matrix metalloproteinases.

Abstract: Suggested is a cosmetic composition, comprising compounds of formula (I) wherein R and R? independently of one another denote hydrogen, hydroxyl, a linear or branched OC1-C4-alkyl group, or optionally R and R? form together a methylenedioxy group resulting in a 3,4-methylendioxyphenyl residue and R? denotes a linear or branched C1-C9 alkyl group or A, wherein A denotes formula (II) with X, Y and Z being independently of one another hydrogen, hydroxyl, an linear or branched C1-C4-alkyl group, or a linear or branched OC1-C4-alkyl group.

Abstract: The invention relates generally to new compounds of formula (I), wherein R1, R?1, R2, R?2, R3, R?3, R4 R?4, R5, R?5, R6, R7 are independently of one another and denote hydrogen, hydroxyl, C1 to C6-alkyl group or R6 and R7 form together a C5-C6 ring system, and wherein n=0, 1, 2, 3, or 4. Moreover, the invention relates to the use of one or more compounds of formula (I) in cosmetic or pharmaceutical compositions, which are preferably dermatological compositions and are preferably used topically.

Abstract: Novel uses of compounds of the Formula 1 or mixtures of substances that contain one more compounds of the Formula 1, are described. The said compounds are suitable as agents against skin and hair browning, for combating age spots and for the inhibition of the undesired browning of foods.

Abstract: The present invention relates to extracts of Tetraselmis sp., preferably Tetraselmis suecica, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Tetraselmis sp., preferably Tetraselmis suecica.

Abstract: The invention relates generally to new compounds of formula (I), wherein R1, R?1, R2, R?2, R3, R?3, R4 R?4, R5, R?5, R6, R7 are independently of one another and denote hydrogen, hydroxyl, C1 to C6-alkyl group or R6 and R7 form together a C5-C6 ring system, and wherein n=0, 1, 2, 3, or 4. Moreover, the invention relates to the use of one or more compounds of formula (I) in cosmetic or pharmaceutical compositions, which are preferably dermatological compositions and are preferably used topically.

Abstract: Ginger extract compositions containing 25 to 30% b.w. [6]-gingerol, 5 to 10% b.w. [8]-gingerol, 5 to 10% b.w. [10]-gingerol, 1.5 to 4% b.w. [6]-shogaol, 0.3 to 1.3% b.w. [8]-shogaol, 0.03 to 1% b.w. [10]-shogaol and 0.01 to 1% b.w. zingerone, with the amount of gingerols totaling 35 to 50% b.w. and the amount of shogaols totaling 1.5 to 6% b.w.

Abstract: Suggested is a cosmetic composition, comprising compounds of formula (I) wherein R and R? independently of one another denote hydrogen, hydroxyl, a linear or branched OC1-C4-alkyl group, or optionally R and R? form together a methylenedioxy group resulting in a 3,4-methylendioxyphenyl residue and R? denotes a linear or branched C1-C9 alkyl group or A, wherein A denotes formula (II) with X, Y and Z being independently of one another hydrogen, hydroxyl, an linear or branched C1-C4-alkyl group, or a linear or branched OC1-C4-alkyl group.

Abstract: The present invention relates to formulations having an irritation-reducing action, corresponding cosmetic and pharmaceutical products as well as associated methods and uses thereof.

Abstract: Suggested is a ginger extract, comprising (a) 25 to 30% b.w. [6]-gingerol (b) 5 to 10% b.w. [8]-gingerol (c) 5 to 10% b.w. [10]-gingerol (d) 1.5 to 4% b.w. [6]-shogaol (e) 0.3 to 1.3% b.w. [8]-shogaol; (f) 0.03 to 1% b.w. [10]-shogaol; (g) 0.01 to 1% b.w. zingerone, on condition that the amount of gingerols sums up to 35 to 50% b.w. and the amount of shogaols sums up to 1.5 to 6% b.w.

Abstract: The invention relates to a cosmetic, dermatological or pharmaceutical preparation, containing one, two or more compounds of formula (I) and/or a pharmaceutically acceptable salt of a compound of this type, (i) for use in a method for preventing, treating or reducing cellulite, and/or (ii) in an adequate quantity to reduce the lipid quantity contained in subcutaneous fat tissue, and/or to inhibit the differentiation of preadipocytes, and/or to inhibit the lipogenesis in adipocytes, wherein the radicals R1 to R8, independently of one another, signify hydrogen, hydroxy or C1-C4-alkoxy, and/or two adjacent radicals together form a methylenedioxy group.

Abstract: The present invention relates primarily to the use of locust tree (Gleditsia) wood or heartwood extracts as anti-cellulite active substances. The present invention further relates to certain locust-tree wood extracts and mixtures containing locust-tree wood extracts and corresponding cosmetic, dermatological or pharmaceutical preparations, which are suitable in particular for the prevention and treatment of cellulite in humans.

Abstract: The use of specific compounds of the Formula 1 (and also corresponding mixtures) in particular as cosmetic agents for the inhibition of the substance P-induced release of histamine from mast cells is described.

Abstract: The present invention concerns the field of plant extracts and their uses, in particular for cosmetic, oral hygiene and pharmaceutical purposes. In particular the invention concerns blackberry leaf extracts and preparations and medicaments containing them, as well as their use to inhibit irritating and inflammatory skin conditions.

Abstract: The use of specific compounds of the Formula 1 (and also corresponding mixtures) in particular as cosmetic agents for the inhibition of the substance P-induced release of histamine from mast cells is described.